KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Non-Current Assets (2016 - 2025)

Biogen has reported Non-Current Assets over the past 17 years, most recently at $20.5 billion for Q4 2025.

  • Quarterly results put Non-Current Assets at $20.5 billion for Q4 2025, down 0.62% from a year ago — trailing twelve months through Dec 2025 was $81.5 billion (changed 0.09% YoY), and the annual figure for FY2025 was $20.5 billion, down 0.62%.
  • Non-Current Assets for Q4 2025 was $20.5 billion at Biogen, up from $20.3 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for BIIB hit a ceiling of $21.5 billion in Q3 2024 and a floor of $14.7 billion in Q2 2023.
  • Median Non-Current Assets over the past 5 years was $18.5 billion (2021), compared with a mean of $18.0 billion.
  • Biggest five-year swings in Non-Current Assets: fell 11.26% in 2022 and later soared 35.38% in 2023.
  • Biogen's Non-Current Assets stood at $16.0 billion in 2021, then fell by 7.85% to $14.8 billion in 2022, then soared by 35.38% to $20.0 billion in 2023, then rose by 3.04% to $20.6 billion in 2024, then decreased by 0.62% to $20.5 billion in 2025.
  • The last three reported values for Non-Current Assets were $20.5 billion (Q4 2025), $20.3 billion (Q3 2025), and $20.4 billion (Q2 2025) per Business Quant data.